It's been a productive couple of weeks for Aratana Therapeutics. I had the opportunity to sit down with Aratana CEO Steven St. Peter last week to chat about recent developments, and more generally, the prospects for the animal health industry going forward. Here are some excerpts from our conversation.
The National Pork Board has launched an online marketing campaign to direct consumers to websites that support the use of antibiotics in livestock following a television documentary critical of the practice.
The industry group emailed its strategy to food and agriculture leaders ahead of the airing earlier this week of the documentary "The Trouble with Antibiotics" on the PBS Frontline program, Reuters reported.
It is fascinating what has happened in the last couple of years in the animal health industry, which runs to $22 billion a year for animal drugs and vaccines and is expected to grow at 5.7% compound annual rate, faster than the market for human medicines. Zoetis was spun off from Pfizer as the largest independent animal health company. M&A action in recent months is remixing the players once again. Next year, Novartis will be off of this list, and based on current revenues, Eli Lilly's Elanco should ascend to the number two position.
Many, but not all, of the largest are units of Big Pharma. One of the things you might notice is the range in size from largest to smallest, $4.56 billion, to $413 million. Given the current M&A atmosphere, there is a good chance that another player could be spun off, or sold, reshuffling the deck once again.
POPULAR COMMENT THREADS
Dublin-based Nexvet Biopharma has become the first company to launch a pivotal clinical trial of a monoclonal antibody (mAb) designed to combat pain in dogs with osteoarthritis.
Veterinary medicine researchers at Kansas State University and scientists at Lawrence Livermore National Laboratory have teamed to advance the development of diagnostic tools used to detect infectious diseases, including porcine-related afflictions.
PetMed Express CEO Menderes Akdag raised a few eyebrows when he blamed his company's missed quarterly profit and sales targets on the weather.
VCA, which manages the largest network of veterinary hospitals and labs in the U.S., announced Thursday night that its revenues grew 7.7% to a record $499.6 million in the third quarter. The company credited the positive results in part to its acquisition of 13 independent animal hospitals with combined annual revenues of $26 million.
A full 22 U.S. states don't have enough veterinarians in rural areas to keep livestock healthy. So for the second year in a row, the U.S. Department of Agriculture's National Institute of Food and Agriculture is helping veterinary students defray tuition costs, provided they agree to work in an underserved area for three years.
Growing interest in the microbiome--the vast colony of microbes that live in our guts--has turbocharged sales of everything from probiotic supplements to yogurts containing so-called beneficial bugs. Now that enthusiasm is poised to spill over into the animal health market.
From Our Sister Sites
WuXi PharmaTech has struck a deal with the genomics experts at Foundation Medicine, signing on to offer the company's cancer-decoding services to drug developers in its native China.
Denmark-based Novo Nordisk said on Friday that it had received a subpoena from a U.S. Attorney who wants some info about its manufacturing operations at a plant in Kalundborg. But the company said it really has no idea why.